139 related articles for article (PubMed ID: 9869272)
1. (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors.
Iga Y; Arisawa H; Ogane N; Saito Y; Tomizuka T; Nakagawa-Yagi Y; Masunaga H; Yasuda H; Miyata N
Jpn J Pharmacol; 1998 Nov; 78(3):373-80. PubMed ID: 9869272
[TBL] [Abstract][Full Text] [Related]
2. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
3. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
Arisawa H; Imai E; Fujise N; Fukui K; Masunaga H
Arzneimittelforschung; 2002; 52(1):14-20. PubMed ID: 11838269
[TBL] [Abstract][Full Text] [Related]
4. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.
Arisawa H; Fukui K; Imai E; Fujise N; Masunaga H
Arzneimittelforschung; 2002; 52(4):225-32. PubMed ID: 12040964
[TBL] [Abstract][Full Text] [Related]
5. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
Arisawa H; Fukui K; Fujise N; Masunaga H
Arzneimittelforschung; 2002; 52(2):81-8. PubMed ID: 11878203
[TBL] [Abstract][Full Text] [Related]
6. Salivary secretion and histopathological effects after single administration of the muscarinic agonist SNI-2011 in MRL/lpr mice.
Iwabuchi Y; Katagiri M; Masuhara T
Arch Int Pharmacodyn Ther; 1994; 328(3):315-25. PubMed ID: 7542865
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 3rd communication: effects on respiratory and cardiovascular systems.
Arisawa H; Fukui K; Masunaga H
Arzneimittelforschung; 2002; 52(3):162-7. PubMed ID: 11963642
[TBL] [Abstract][Full Text] [Related]
8. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs.
Masunaga H; Ogawa H; Uematsu Y; Tomizuka T; Yasuda H; Takeshita Y
Eur J Pharmacol; 1997 Nov; 339(1):1-9. PubMed ID: 9450610
[TBL] [Abstract][Full Text] [Related]
10. Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sjörgen's syndrome.
Iwabuchi Y; Masuhara T
Gen Pharmacol; 1994 Jan; 25(1):123-9. PubMed ID: 7517901
[TBL] [Abstract][Full Text] [Related]
11. [Cevimeline hydrochloride hydrate (Saligren capsule 30 mg): a review of its pharmacological profiles and clinical potential in xerostomia].
Shiozawa A
Nihon Yakurigaku Zasshi; 2002 Oct; 120(4):253-8. PubMed ID: 12425151
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of the novel muscarinic receptor agonist SNI-2011 in rats and dogs.
Washio T; Kohsaka K; Arisawa H; Masunaga H
Arzneimittelforschung; 2003; 53(1):26-33. PubMed ID: 12608011
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemistry-based study on aquaporin (AQP)-1, 3, 4, 5 and 8 in the parotid glands, submandibular glands and sublingual glands of Sjögren's syndrome mouse models chronically administered cevimeline.
Nakamura M; Saga T; Watanabe K; Takahashi N; Tabira Y; Kusukawa J; Yamaki K
Kurume Med J; 2013; 60(1):7-19. PubMed ID: 23925155
[TBL] [Abstract][Full Text] [Related]
14. Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice.
Nishimura H; Yakeishi A; Saga T; Yamaki K
Kurume Med J; 2009; 56(3-4):39-47. PubMed ID: 20505281
[TBL] [Abstract][Full Text] [Related]
15. Lowered susceptibility of muscarinic receptor involved in salivary secretion of streptozotocin-induced diabetic rats.
Watanabe M; Yamagishi-Wang H; Kawaguchi M
Jpn J Pharmacol; 2001 Oct; 87(2):117-24. PubMed ID: 11700010
[TBL] [Abstract][Full Text] [Related]
16. Effects of cevimeline on excitability of parasympathetic preganglionic neurons in the superior salivatory nucleus of rats.
Mitoh Y; Ueda H; Ichikawa H; Fujita M; Kobashi M; Matsuo R
Auton Neurosci; 2017 Sep; 206():1-7. PubMed ID: 28600120
[TBL] [Abstract][Full Text] [Related]
17. Characterization of muscarinic cholinergic receptors in the submandibular gland of the rat.
Costa LG; Murphy SD
J Auton Nerv Syst; 1985 Aug; 13(4):287-301. PubMed ID: 4031365
[TBL] [Abstract][Full Text] [Related]
18. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
Moret C; Pastrie I; Briley M
Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
[TBL] [Abstract][Full Text] [Related]
19. Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Yuan Z; Iida H; Inoue N; Ishikawa Y; Ishida H
Eur J Pharmacol; 2003 Mar; 464(2-3):197-206. PubMed ID: 12620514
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
